The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...

Pharmaceuticals announced that the U.S. FDA has approved Revuforj as the first and only menin inhibitor for the treatment of ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...

Cereno Scientific has secured loan financing to continue developing CS1, its lead therapeutic candidate for pulmonary ...

Critics believe Donald Trump's nominee to lead Health and Human Services poses a threat to the achievements of a ...

Shipments of Zyn's nicotine pouches in 2023 were up 62% year over year.

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

The Discovery Patch collects the sweat samples which can then be used for drug and hydration analysis. "Intelligent gears up ...

Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...